Suppr超能文献

外泌体:用于治疗诊断的生物制药纳米载体

Exosomes: Biological Pharmaceutical Nanovectors for Theranostics.

作者信息

Thomas Shindu C, Kim Jin-Woo, Pauletti Giovanni M, Hassett Daniel J, Kotagiri Nalinikanth

机构信息

Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, United States.

Department of Biological and Agricultural Engineering, Institute for Nanoscience and Engineering, University of Arkansas, Fayetteville, AR, United States.

出版信息

Front Bioeng Biotechnol. 2022 Jan 12;9:808614. doi: 10.3389/fbioe.2021.808614. eCollection 2021.

Abstract

Exosomes are natural cell-derived nanovesicles of endocytic origin that enable cellular crosstalk by transferring encapsulated molecular cargos across biological barriers, thereby holding significantly complex implications in the etiology and progression of diverse disease states. Consequently, the development of exosomes-based nano-theranostic strategies has received immense consideration for advancing therapeutic interventions and disease prognosis. Their favorable biopharmaceutical properties make exosomes a unique nanoparticulate carrier for pharmaceutical drug delivery. This review provides an update on the contemporary strategies utilizing exosomes for theranostic applications in nanomedicine. In addition, we provide a synopsis of exosomal features and insights into strategic modifications that control biodistribution. We further discuss their opportunities, merits and pitfalls for cell/tissue targeted drug delivery in personalized nanotherapy.

摘要

外泌体是源自细胞的天然内吞纳米囊泡,可通过跨生物屏障传递封装的分子货物实现细胞间通讯,因此在多种疾病状态的病因和进展中具有极为复杂的影响。因此,基于外泌体的纳米诊疗策略的发展在推进治疗干预和疾病预后方面受到了广泛关注。它们良好的生物制药特性使外泌体成为药物递送的独特纳米颗粒载体。本综述提供了利用外泌体进行纳米医学诊疗应用的当代策略的最新进展。此外,我们概述了外泌体的特征,并深入探讨了控制生物分布的策略性修饰。我们还讨论了它们在个性化纳米治疗中进行细胞/组织靶向药物递送的机会、优点和缺陷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7e/8790084/fee8fc56d69c/fbioe-09-808614-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验